AL
MDT icon

Aspiriant LLC’s Medtronic MDT Stock Holding History

Aspiriant LLC’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$482K Buy
5,559
+2,000
+56% +$192K 0.01% 223
2025
Q4 		$342K Buy
3,559
+324
+10% +$31.5K 0.01% 259
2025
Q3 		$308K Sell
3,235
-38
-1% -$3.49K 0.01% 247
2025
Q2 		$285K Sell
3,273
-133
-4% -$11.3K 0.01% 263
2025
Q1 		$306K Buy
+3,406
New +$305K 0.01% 233
2024
Q2 		– Sell
-2,592
Closed -$226K – 314
2024
Q1 		$226K Sell
2,592
-380
-13% -$32.4K 0.01% 294
2023
Q4 		$245K Sell
2,972
-559
-16% -$42.6K 0.01% 268
2023
Q3 		$277K Buy
3,531
+786
+29% +$65.8K 0.01% 237
2023
Q2 		$242K Buy
2,745
+138
+5% +$11.9K 0.01% 253
2023
Q1 		$210K Buy
+2,607
New +$212K 0.01% 263
2022
Q4 		– Sell
-3,028
Closed -$245K – 286
2022
Q3 		$245K Sell
3,028
-188
-6% -$16.9K 0.01% 228
2022
Q2 		$289K Buy
3,216
+1,136
+55% +$115K 0.01% 217
2022
Q1 		$231K Buy
+2,080
New +$220K 0.01% 254
2018
Q4 		– Sell
-2,029
Closed -$200K – 243
2018
Q3 		$200K Buy
+2,029
New +$188K 0.02% 231
2018
Q2 		– Sell
-3,429
Closed -$275K – 256
2018
Q1 		$275K Buy
+3,429
New +$283K 0.02% 200

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aspiriant LLC's MDT Position: Q1 2026 in Review

Aspiriant LLC increased its Medtronic (MDT) stake by 56% in Q1 2026, buying an estimated $192K and bringing the position to 5,559 shares worth $482K. The position accounts for 0.01% of the portfolio, ranked #223.

Aspiriant LLC first reported a position in MDT in Q1 2018 and has held it in 15 quarters since. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Aspiriant LLC held 5,559 shares of Medtronic worth $482K as of Q1 2026.
  • Aspiriant LLC bought 2,000 Medtronic shares in Q1 2026, an estimated $192K.
  • Medtronic made up 0.01% of Aspiriant LLC's portfolio in Q1 2026, its #223 holding.
  • Aspiriant LLC first reported a position in Medtronic in Q1 2018 and has held it in 15 quarters since.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.